Albendazole dosage and administration: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Albendazole}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [AMEDRA PHARMACEUT..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Dosage and Administration== | |||
Dosing of ALBENZA will vary, depending upon which of the following parasitic infections is being treated. In young children, the tablets should be crushed or chewed and swallowed with a drink of water. | |||
{| | |||
| [[File:ALBENZA03.jpg|800px|thumb]] | |||
|} | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [AMEDRA PHARMACEUTICALS LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845 | publisher = | date = | accessdate = }}</ref> | Patients being treated for neurocysticercosis should receive appropriate steroid and anticonvulsant therapy as required. Oral or intravenous corticosteroids should be considered to prevent cerebral hypertensive episodes during the first week of treatment.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [AMEDRA PHARMACEUTICALS LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== |
Latest revision as of 00:10, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosage and Administration
Dosing of ALBENZA will vary, depending upon which of the following parasitic infections is being treated. In young children, the tablets should be crushed or chewed and swallowed with a drink of water.
Patients being treated for neurocysticercosis should receive appropriate steroid and anticonvulsant therapy as required. Oral or intravenous corticosteroids should be considered to prevent cerebral hypertensive episodes during the first week of treatment.[1]
References
Adapted from the FDA Package Insert.